Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Eli Lilly Obesity Pipeline: Key Candidates to Watch Eli Lilly is at the forefront of developing innovative therapies to combat obesity, with several promising GLP-1 therapies in its pipeline
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, research presented at the 38th Annual Congress of the European Association of Nuclear Medicine revealed
The GLP-1 RAs are approved for the treatment of type 2 diabetes (T2D) and obesity
J Headache Pain 22(1):86
US$ 28.36
US$ 29.10
US$ 22.86
US$ 27.90
US$ 28.78
US$ 24.52
US$ 29.26
US$ 25.13
US$ 21.33
US$ 26.73
